User talk:Newscholar001

August 2017
Welcome to Wikipedia. It might not have been your intention, but you recently removed maintenance templates from Varlitinib. When removing maintenance templates, please be sure to either resolve the problem that the template refers to, or give a valid reason for the removal in the edit summary. Please see Help:Maintenance template removal for further information on when maintenance templates should or should not be removed. If this was a mistake, don't worry, as your removal of this template has been reverted. Take a look at the welcome page to learn more about contributing to this encyclopedia, and if you would like to experiment, please use the sandbox. Thank you. pseudonym Jake Brockman talk 08:41, 11 August 2017 (UTC)

Relationship with users/organisations
Dear Newscholar001, welcome to Wikipedia and many thanks for your contributions. The article for Varlitinib was recently created by an editor whose username implied a close connection with the firm developing this drug. As this gives concern for conflicts of interest and promotional activity, that username was blocked. It appears you created your username after that user was blocked and continued editing the article. This may imply you are somehow connected. May I please ask you to disclose your relationship with both the original user and the company Aslan Pharma. As per conflict of interest policy, any relationships with the topics written about must be disclosed and direct editing is strongly discouraged. Similarly, undisclosed relationships between users, especially when blocked for policy concerns, may fall under sock puppetry considerations. Many thanks. pseudonym Jake Brockman talk 08:50, 11 August 2017 (UTC)

No Relations with that company
Dear Jack Broackman, I am currently a student working on a project in school. I am researching about anti-cancer therapy drugs and Aslan Pharma came up. I saw their pipeline and concluded that Valitinib was their most advanced drug. I concluded that not many people know about this drug so I did some research and thought I would make a contribution onto Wikipedia and make a post about this study drug. I have no relations with that company, I just couldnt think of any names at the moment so I took that company's name. But I will use this username from now on.
 * Many thanks for clarifying. Please take a moment to look at the welcome page to help you get started on your journey on Wikipedia. Especially the simplified ruleset should help you get started if you are interested in creating new articles. Any questions, please leave a message on my talk page.pseudonym Jake Brockman talk 09:29, 11 August 2017 (UTC)

Article deletion
Hi Newscholar001. I noticed you blanked the contents of your article about Varlitinib and posted an AfD message for deletion. I was wondering if it really is your intention to delete the article? If so, the process is a bit different and another tag needs to be placed. I have done this. If the AfD tag was a mistake and you did not intend to delete the article, please let me know. pseudonym Jake Brockman talk 06:20, 16 August 2017 (UTC)